CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-13 | Boyer David W. Chief Corp. Affairs Officer | Shares withheld for taxes | −832 | $124.12 | $103K | 6,158 |
| 2026-02-13 | Boyer David W. Chief Corp. Affairs Officer | Option exercise | +1,811 | 7,969 | ||
| 2026-02-13 | Boyer David W. Chief Corp. Affairs Officer | Shares withheld for taxes | −978 | $124.12 | $121K | 6,991 |
| 2026-02-13 | Boyer David W. Chief Corp. Affairs Officer | Grant or award | +9,968 | 16,959 | ||
| 2026-02-13 | Boyer David W. Chief Corp. Affairs Officer | Shares withheld for taxes | −5,378 | $124.12 | $668K | 11,581 |
| 2026-02-13 | Boyer David W. Chief Corp. Affairs Officer | Option exercise · Restricted Stock Unit | −1,541 | 3,083 | ||
| 2026-02-13 | Boyer David W. Chief Corp. Affairs Officer | Option exercise · Restricted Stock Unit | −1,811 | 1,812 | ||
| 2026-02-13 | Boyer David W. Chief Corp. Affairs Officer | Grant or award · Stock Option | +31,234 | 31,234 | ||
| 2026-02-13 | Boyer David W. Chief Corp. Affairs Officer | Grant or award · Restricted Stock Unit | +5,479 | 5,479 | ||
| 2026-02-13 | Onyia Jude Chief Scientific Officer | Option exercise | +2,690 | 19,801 | ||
| 2026-02-13 | Onyia Jude Chief Scientific Officer | Shares withheld for taxes | −1,452 | $124.12 | $180K | 18,349 |
| 2026-02-13 | Onyia Jude Chief Scientific Officer | Option exercise | +2,717 | 21,066 | ||
| 2026-02-13 | Onyia Jude Chief Scientific Officer | Shares withheld for taxes | −1,466 | $124.12 | $182K | 19,600 |
| 2026-02-13 | Onyia Jude Chief Scientific Officer | Grant or award | +19,935 | 39,535 | ||
| 2026-02-13 | Onyia Jude Chief Scientific Officer | Shares withheld for taxes | −10,755 | $124.12 | $1.3M | 28,780 |
| 2026-02-13 | Onyia Jude Chief Scientific Officer | Option exercise · Restricted Stock Unit | −2,690 | 5,380 | ||
| 2026-02-13 | Onyia Jude Chief Scientific Officer | Option exercise · Restricted Stock Unit | −2,717 | 2,717 | ||
| 2026-02-13 | Onyia Jude Chief Scientific Officer | Grant or award · Stock Option | +55,119 | 55,119 | ||
| 2026-02-13 | Onyia Jude Chief Scientific Officer | Grant or award · Restricted Stock Unit | +9,669 | 9,669 | ||
| 2026-02-13 | Keswani Sanjay Chandru Chief Medical Officer | Grant or award · Stock Option | +35,827 | 35,827 |
Page 9 of 37 · 740 trades